NCT01727492

Brief Summary

The current study is a dubble-blinde placebo-controlled cross-over study verifying the preventive effect of antioxidants on noise-induced hearing loss (NIHL) and noise-induced tinnitus (NIT). The antioxidants comprise of a mixture of magnesium and n-acetylcystein which should be taken 1h before leisure noise above 100dB for at least 30 minutes.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2012

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2012

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 16, 2012

Completed
Last Updated

November 6, 2013

Status Verified

November 1, 2013

First QC Date

September 28, 2012

Last Update Submit

November 5, 2013

Conditions

Keywords

preventionnoise-induced tinnitusnoise-induced hearing lossyoung population

Outcome Measures

Primary Outcomes (1)

  • Protection against noise-induced tinnitus due to antioxidants

    Antioxidants protect against temporary threshold shift. The most prevalent cause of noise-induced tinnitus is noise-induced hearing loss. Therefore, it is assumed that the preventive intake of antioxidants prior to a loud event, might protect against threshold shift as well as noise-induced tinnitus. A 50% decrease of tinnitus loudness scored on a Visual Analogue Scale (VAS) compared to placebo trials is expected.

Secondary Outcomes (1)

  • Change of tinnitus duration

Other Outcomes (1)

  • Decrease of temporary threshold shift in antioxidant trials compared to placebo trials

Study Arms (2)

sugar pill

PLACEBO COMPARATOR

Antioxidantia

ACTIVE COMPARATOR

Dosage: 600mg n-acetylcystein and 200mg magnesium intake: 1 hour before leisure noise exposure above 100dB of at least 30 minutes frequency: 4 separate events (2x placebo, 2x antioxidants)

Drug: Antioxidantia

Interventions

Antioxidantia

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age: 18-25 years old
  • Temporary tinnitus after noise exposure: loudness \>5 on a VAS

You may not qualify if:

  • middle ear problems
  • Allergy for magnesium or n-acetylcystein
  • Use of hearing protection when going out

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Antwerp University Hospital

Antwerp, Edegem, 2650, Belgium

RECRUITING

Related Publications (1)

  • Gilles A, Ihtijarevic B, Wouters K, Van de Heyning P. Using prophylactic antioxidants to prevent noise-induced hearing damage in young adults: a protocol for a double-blind, randomized controlled trial. Trials. 2014 Apr 5;15:110. doi: 10.1186/1745-6215-15-110.

MeSH Terms

Conditions

TinnitusHearing Loss, Noise-Induced

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsHearing Loss, SensorineuralHearing Loss

Central Study Contacts

Annick Gilles, Master

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ethics Comittee UZ Antwerpen

Study Record Dates

First Submitted

September 28, 2012

First Posted

November 16, 2012

Study Start

November 1, 2012

Last Updated

November 6, 2013

Record last verified: 2013-11

Locations